BioNTech SE 2022 AR2
The report highlights BioNTech's strategic progress and financial performance in 2022, driven by the global success of its COVID-19 vaccine franchise, with approximately two billion doses invoiced. The company advanced its diversified pipeline to 26 clinical-stage candidates across oncology and infectious diseases, including five randomized Phase 2 trials in oncology. BioNTech expanded its global footprint by breaking ground on its first African mRNA manufacturing facility in Rwanda and acquiring a GMP site in Singapore. Additionally, the company committed to a 42% absolute reduction in Scope 1 and 2 greenhouse gas emissions by 2030 and announced the strategic acquisition of AI company InstaDeep to enhance its digital and drug discovery capabilities.
Company: BioNTech SE
Sector: Professional & technical services
Country: Germany
Year: 2022
Type: AR2
Pages: 276
Back to company
BioNTech SE
Annual Report
The report highlights BioNTech's strategic progress and financial performance in 2022, driven by the global success of its COVID-19 vaccine franchise, with approximately two billion doses invoiced. The company advanced its diversified pipeline to 26 clinical-stage candidates across oncology and infectious diseases, including five randomized Phase 2 trials in oncology. BioNTech expanded its global footprint by breaking ground on its first African mRNA manufacturing facility in Rwanda and acquiring a GMP site in Singapore. Additionally, the company committed to a 42% absolute reduction in Scope 1 and 2 greenhouse gas emissions by 2030 and announced the strategic acquisition of AI company InstaDeep to enhance its digital and drug discovery capabilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Apr 21, 2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees